Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Titel:
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Auteur:
Berdeja, Jesus G Madduri, Deepu Usmani, Saad Z Jakubowiak, Andrzej Agha, Mounzer Cohen, Adam D Stewart, A Keith Hari, Parameswaran Htut, Myo Lesokhin, Alexander Deol, Abhinav Munshi, Nikhil C O'Donnell, Elizabeth Avigan, David Singh, Indrajeet Zudaire, Enrique Yeh, Tzu-Min Allred, Alicia J Olyslager, Yunsi Banerjee, Arnob Jackson, Carolyn C Goldberg, Jenna D Schecter, Jordan M Deraedt, William Zhuang, Sen Hong Infante, Jeffrey Geng, Dong Wu, Xiaoling Carrasco-Alfonso, Marlene J Akram, Muhammad Hossain, Farah Rizvi, Syed Fan, Frank Lin, Yi Martin, Thomas Jagannath, Sundar